Table 1 Study characteristics – population characteristics
From: Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis
| Study characteristics | Number of studies (%) |
|---|---|
| Region of studya | |
| Andean Latin America | 2 (0.5) |
| Central Asia | 3 (0.8) |
| East Asia | 12 (3.1) |
| North Africa & Middle East | 17 (4.4) |
| South Asia | 276 (71) |
| Southeast Asia | 38 (9.8) |
| Sub-Saharan Africa, Central | 6 (1.5) |
| Sub-Saharan Africa, Eastern | 14 (3.6) |
| Sub-Saharan Africa, Western | 21 (5.4) |
| Number of blood cultures screened | |
| 0-99 | 13 (3.4) |
| 100-499 | 43 (11.2) |
| 500-999 | 30 (7.8) |
| 1000-4999 | 49 (12.8) |
| 5000+ | 59 (15.4) |
| Not stated | 190 (49.5) |
| Specific age groups | |
| Adults only | 5 (1.3) |
| Children only | 68 (17.7) |
| No specified age restrictions/Adults and children | 311 (81) |
| Reported pre-admission antibiotic use (proportion of patients in the study)b | |
| 0 | 19 (4.9) |
| 1-25% | 15 (3.8) |
| 26-50% | 13 (3.3) |
| 51-75% | 7 (1.8) |
| 76-100% | 7 (1.8) |
| Not stated | 329 (84.4) |
| Reported case fatality rate | |
| 0 | 61 (15.9) |
| 1-5% | 24 (6.3) |
| 6-10% | 2 (0.5) |
| 11-15% | 1 (0.3) |
| 16-20% | 2 (0.5) |
| 21-25% | 1 (0.3) |
| Not stated | 293 (76.3) |
| Patient typec | |
| Inpatients | 73 (19) |
| Outpatients | 14 (3.6) |
| Outpatients & Emergency department | 6 (1.6) |
| Inpatients & Outpatients | 44 (11.4) |
| Community | 7 (1.8) |
| Not specified | 241 (62.6) |
